Skip to main content

racism

Association of Race With Urine Toxicology Testing Among Pregnant Patients

Drs. Jarlenski, Brown-Podgorski, and Krans sought to understand associations between race, receiving urine toxicology testing, and positive test results among pregnant patients. Findings show that Black patients experience increased drug testing practices.

Read more about their findings here: https://jamanetwork.com/journals/jama-health-forum/fullarticle/2803729

Barriers to Diagnosis of Postpartum Depression among Younger Black Mothers

Drs. Ashley Hill and Natacha De Genna qualitatively examined coping mechanisms and desired supports in pregnant and birthing Black and biracial adolescent and young adult women during the COVID-19 pandemic. Their team found that nearly half the interviewees reported mental health symptoms consistent with postpartum depression and that several were afraid to disclose their symptoms to a healthcare provider due to fear of child protective services involvement and their belief they would be treated unfairly because of their race. 

Estimation of Multiyear Consequences for Abortion Access in Georgia Under a Law Limiting Abortion to Early Pregnancy

Dr. Liz Mosley and her team found that Georgia’s law limiting abortion to early pregnancy would eliminate access to abortion for nearly 90% of patients in Georgia and disproportionately harm patients who are Black, younger, and in lower socioeconomic status groups.

Read more here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2802001

Measures of Racism and Discrimination in Preterm Birth Studies

Dr. Ashley Hill and her team examined literature on measures of racial discrimination used in preterm birth research and found that assessment methods and application of constructs varied. This synthesis shows significant challenges to understanding associations between racial discrimination and preterm birth, which ultimately hinders development of effective intervention.
 

Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder During Pregnancy

Alice Gao, Dr. Liz Krans, and Dr. Marian Jarlenski found that later diagnosis of opioid use disorder (OUD) in pregnancy among non-White/Hispanic women partially explains the disparities in medication for opioid use disorder (MOUD) receipt in this population. Universal substance use screening earlier in pregnancy, combined with connecting patients to evidence-based and culturally competent care, is an approach that could close the observed racial-ethnic disparity in MOUD receipt.